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Symptomatic atherosclerosis in young patients is asso-
ciated with premature cardiovascular death.8 An increased
risk of death has been reported for young patients with
severe aortoiliac disease,9,10 cerebrovascular disease,11,12
and atherosclerotic infrainguinal disease.9,13-15 However,
data describing the survival patterns for young patients
treated for AAA are incomplete.
The purpose of this study was to describe the associ-
ated cardiovascular disease, perioperative results, and sur-
vival rate after surgical repair of degenerative
(atherosclerotic) AAA in young patients (≤50 years) com-
pared with those of a randomly selected comparison group
of older patients who also underwent AAA repair. In addi-
tion, survival rates and causes of death in the young
patients were compared with those of the entire patient
cohort who underwent AAA repair during the study
period.
METHODS
Patient data. We reviewed hospital records to identify
all patients who had operative repair of an AAA at Wake
Forest University Baptist Medical Center between Jan 1,
1988, and Mar 31, 2000. Medical records were reviewed
for patients ≤50 years at the time of operation and for ran-
domly selected control patients (3 control subjects for each
Abdominal aortic aneurysms (AAAs) are thought to
be a disease of the elderly.1 Whether evaluated by means of
necropsy2,3 or screening ultrasound scanning,4,5 the
prevalence of AAA increases with age. Operative repairs of
AAAs are also more common in the elderly.6 However,
AAAs in young patients are rare, and patients younger
than 50 years have been excluded from population-based
AAA studies.5,7
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Purpose: This study assessed the cardiovascular disease, perioperative results, and survival after surgical abdominal aor-
tic aneurysm repair in young patients (≤ 50 years) compared with randomly selected older patients who also underwent
abdominal aortic aneurysm repair.
Methods: We reviewed hospital records to identify young and randomly selected control patients (3 for each young
patient, ≥ 65 years, matched for year of operation) with degenerative (atherosclerotic) abdominal aortic aneurysms
undergoing repair between Jan 1, 1988, and Mar 31, 2000. Patients with congenital aneurysms, pseudoaneurysms,
aortic dissections, post-coarctation dilations, aortic infection, arteritis, or aneurysms isolated to the thoracic aorta were
excluded. Mortality data and cause of death were obtained from medical records and the National Death Index.
Results: Among 1168 patients who underwent abdominal aortic aneurysm repairs, 19 young patients (1.6%) and 57
control patients were identified. The mean age was 48.4 years in the young group and 72.2 years in the control group.
There were no differences in sex or race between the two groups. When comparing existing cardiovascular disease
between the groups, there were no differences in the incidence of earlier coronary revascularization (26% vs 16%) or
non-cardiac vascular surgery (5% vs 9%), but aneurysms were more commonly symptomatic in young patients (53% vs
21%; P < .01). Aneurysmal disease was limited to the infrarenal aorta in similar proportions of patients (89% vs 88%).
No statistically significant differences were seen in the incidence of perioperative deaths (16% young vs 9% control; P
= .40) or postoperative complications (37% young vs 26% control; P = .38). The estimated survival rate of the young
group was not different from that of the control group (3-year survival rate, 73% vs 69%; P = .32) or the entire cohort
of patients (older than 50 years; n = 1101) who underwent repair of abdominal aortic aneurysms during the study
period (3-year survival 73% vs 75%; P = .63).
Conclusion: After abdominal aortic aneurysm repair, young patients had perioperative results and follow-up mortality rates
similar to those of control patients. Cardiovascular disease was the predominant cause of death after abdominal aortic
aneurysm repair in the young patients. When compared with an age older than 50 years at the time of abdominal aortic
aneurysm repair, young age alone was not associated with increased survival. (J Vasc Surg 2002;35:94-9.)
younger patient, 65 years or older, matched for year of
operation). A random number chart was used as a means of
randomly selecting the control patients from the entire
cohort of patients undergoing AAA repair during the study
period. Patients with congenital aneurysms, anastamotic or
traumatic pseudoaneurysms, acute or chronic complica-
tions of aortic dissections, post-coarctation dilations,
arteritis, infectious aneurysms, or aneurysms isolated to the
thoracic aorta were excluded from analysis.
With published reporting standards, we abstracted
data including demographics, atherosclerotic risk factors
and cardiovascular disease, family history of aneurysmal or
coronary artery disease, and comorbid conditions.16,17
Aneurysm size and extent were determined with abdomi-
nal computed tomography or ultrasound scanning and the
operative note. Complex repair was defined as repair of an
aneurysm involving the juxtarenal or suprarenal aorta or
AAA repair combined with renal revascularization.
Postoperative complications were recorded according to
recommended standards,16 and pathology reports from
aortic wall specimens were reviewed.
Mortality data and cause of death were obtained from
the medical records and a National Death Index (NDI)
search. The NDI is a computerized database containing
death record information from state vital statistics offices
and, at the time of our search, contained information for
all deaths in the United States between January 1979 and
December 1998. Mortality and cause of death data for
patients undergoing AAA repair after December 1998
(latest NDI data) were obtained from a medical record
review. The survival and cause of death for the entire
cohort of patients undergoing repair of a degenerative
AAA between January 1988 and December 1998 were
also analyzed.
Statistical analysis. The risk factors and perioperative
course of both groups were compared by using the chi-
square test and Fisher exact test. Mortality data were ana-
lyzed by using life-table methods, compared with the
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log-rank test and depicted graphically with Kaplan-Meier
product-limit estimates.18 The effect of atherosclerotic
risk factors and associated cardiovascular disease on sur-
vival was assessed with multivariate Cox proportional haz-
ards models.19 A backward stepwise elimination technique
was used with all factors of interest included in the first
step. Only the factors significant at the .10 level were
included in the final analysis.19 All statistical tests were
considered significant when the P value was less than .05.
RESULTS
Patients. A total of 1168 patients met the inclusion
criteria for repair of AAA during the study period. From
this group, 19 young patients (1.6%) and 57 control
patients were identified (Table I). The mean age was 48.4
years (range, 44-50 years) in the young group and 72.2
years (range, 65-86 years) in the control group. There
were no significant sex (76% men vs 75% men; P = 1.0) or
racial (79% white vs 91% white; P = .22) differences
between the young and control groups.
The prevalence of atherosclerotic risk factors was sim-
ilar between the two groups (Table I). When comparing
the young group with the control group, no differences
were seen in the prevalence of diabetes mellitus (11% vs
11%; P = 1.0), tobacco use (95% vs 86%; P = .43), hyper-
tension (79% vs 81%; P = 1.0), or dyslipidemia (53% vs
35%; P = .16). No differences were noted between the
young and control groups for the prevalence of familial
AAA (5% vs 5%; P = 1.0) or familial cardiac disease (26%
vs 32%; P = .63).
Overall, cardiac disease was significantly less common
in young patients than in control patients (42% vs 68%; P
= .04; Table II). When analyzed by means of severity of
disease, no significant differences between the young and
control groups were seen in the prevalence of severe (0%
vs 5%; P = .42) or moderate (26% vs 32%; P = .61) cardiac
disease. Mild cardiac disease was less prevalent in the
young patients (21% vs 52%; P = .04). However, there was
Table I. Patient demographics and atherosclerotic risk factors
Young patients (n = 19) Control patients (n = 57) P value
Demographics
Age (y, mean ± SD) 48.4 ± 1.9 72.2 ± 4.9
Sex (male) 15 (76%) 43 (75%) 1.0
Race (white) 15 (79%) 52 (91%) .21
Atherosclerotic risk factors*
Tobacco use 18 (95%) 48 (86%) .43
Hypertension 15 (79%) 46 (81%) 1.0
Dyslipidemia 10 (53%) 19 (35%) .16
Obesity (BMI > 25 kg/m2) 9 (53%) 28 (56%) .82
Diabetes mellitus 2 (11%) 6 (11%) .71
Family history
Coronary artery disease 5 (26%) 18 (32%) .63
AAA 1 (5%) 3 (5%) 1.0
*Atherosclerotic risk factors as defined by Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity
ischemia: revised version. J Vasc Surg 1997;26:517-38.
BMI, Body mass index; AAA, abdominal aortic aneurysm.
no difference between the proportion of young patients
and control patients with earlier myocardial revasculariza-
tion (26% vs 16%; P = .32) or non-cardiac vascular surgery
(5% vs 9%; P = 1.0). Finally, the presence of carotid disease
was not significantly different between the young and con-
trol groups (26% vs 43%; P = .20). Aneurysms were more
commonly symptomatic in young patients than in control
patients (53% vs 21%; P < .01), and all patients with symp-
toms had emergency or urgent AAA repair. In the young
patients, symptoms included rupture (16%), pain (21%),
and lower-extremity ischemia (16%). Symptoms in the
control group were rupture (9%), pain (11%), and gas-
trointestinal bleeding from a primary aortoduodenal fis-
tula (2%). However, no differences were noted between
the young and control groups for aneurysm size (5.6 ± 1.6
cm vs 6.0 ± 1.7 cm; P = .18) or extent (89% infrarenal vs
88% infrarenal; P = 1.0). All patients had open AAA repair,
and the need for complex AAA repair was not significantly
different between the young and control groups (32% vs
23%; P = .36).
Outcome. Table III summarizes the procedures and
perioperative deaths among the young patients and the
control patients. The incidence of perioperative deaths was
not significantly different between the young and control
groups (16% vs 9%; P = .40). 
Table IV describes the perioperative morbidity of the
two groups. No significant differences were seen in length
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of stay (intensive care unit or hospital) or perioperative
complications (major, moderate, or minor). Acute renal
failure developed in four patients (three young and one
control), and all died in the perioperative period. Three
young patients were transiently dialyzed, and one patient
(an 86-year-old woman) did not receive dialysis support.
In the control group, three patients (4.2%) were dis-
charged to temporary rehabilitation hospitals, and one
patient (1.4%) returned to her nursing home after surgery,
whereas all young patients were discharged home. 
Follow-up data were available for all patients in the
young and control groups. For the entire cohort of
patients undergoing AAA repair during the study period,
data were available for 96% for a mean period of 45
months. The estimated survival rate of the young group
was not significantly different from that of the control
group (Fig 1). Moreover, when the young group was
compared with the group of all patients older than 50
years who underwent AAA repair during the study period
(1101 patients), the survival distribution was again very
similar (Fig 2).
Causes of death are summarized in Table V. Death was
caused by cardiovascular diseases in 80% of the young
patients, 50% of the control group (P = .28), and 62% 
of patients older than 50 years at the time of AAA repair
(P = .52, compared with the young group). There was
complete agreement between deaths (date and cause)
Table II. Associated diseases at the time of abdominal aortic aneurysm repair among the young and control patients*
Young patients (n = 19) Control patients (n = 57) P value
Cardiac disease 8 (42%) 39 (68%) .04
Severe cardiac disease 0 3 (5%) .42
Moderate cardiac disease 5 (26%) 17 (32%) .61
Mild cardiac disease 3 (21%) 19 (52%) .04
Carotid disease 5 (26%) 24 (43%) .20
Earlier myocardial revascularization 5 (26%) 9 (16%) .32
Earlier non-cardiac revascularization 1 (5%) 5 (9%) 1.0
Renal disease 5 (26%) 17 (30%) .71
Pulmonary disease 10 (53%) 40 (71%) .13
*Associated diseases as defined by Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia:
revised version. J Vasc Surg 1997;26:517-38.
Table III. Summary of perioperative mortality for young and control groups
Sex/age (y) Diagnosis Operation Cause of death
Young group
Male/45 Infrarenal AAA AAA repair Pneumonia/GI bleed/ARF
Male/48 Infrarenal AAA/RA stenosis AAA repair/RA bypass grafting Hemorrhage/MSOD
Male/50 Ruptured infrarenal AAA AAA repair MSOD
Control group
Male/67 Ruptured TAA TAA repair Myocardial infarction
Female/68 Ruptured infrarenal AAA AAA repair MSOD
Male/75 Juxtarenal AAA AAA repair MSOD
Male/78 AAA/aortoduodenal fistula AAA repair MSOD
Female/86 Ruptured infrarenal AAA AAA repair Ischemic bowel/ARF
AAA, Abdominal aortic aneurysm; MSOD, multiple system organ dysfunction; RA, renal artery; ARF, acute renal failure; GI, gastrointestinal; TAA, tho-
racoabdominal aneurysm.
determined by means of medical record review and the
NDI search. 
When atherosclerotic risk factors, markers of cardio-
vascular disease, and age were examined in the young and
control groups, no factors were identified that demon-
strated significant association with death by means of
either univariate or multivariate analysis. However, when
the entire cohort of patients undergoing AAA repair dur-
ing the study period was examined by using univariate
analysis, age was found to be a significant predictor of
death during follow-up (P < .0001). This finding was
influenced by the patients older than 80 years at the time
of AAA repair (intact or ruptured), who had a 12-month
survival rate of 57%.
DISCUSSION
AAAs are rare in patients 50 years old or younger. This
series describes 19 young patients with degenerative (ath-
erosclerotic) aneurysms that required operative repair.
These young patients were compared with 57 control
patients also undergoing AAA repair. The two groups
demonstrated comparable rates of atherosclerotic risk fac-
tors present at the time of AAA repair. Moreover, there
were similar rates of moderate and severe cardiac disease,
carotid disease, and earlier revascularization (both cardiac
and non-cardiac) at the time of operation. Follow-up mor-
tality of the young patients was similar to that of the con-
trol patients and the entire cohort of patients undergoing
repair of AAA during the study period, with cardiovascu-
lar disease being the predominant cause of death. When
compared with patients older than 50 years, young age at
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the time of AAA repair did not protect patients from sub-
sequent cardiovascular mortality.
Because AAAs in young patients are unusual, data
describing this population are limited.20 Muluk et al20
described a series of 26 patients aged 50 years or younger
with aortic aneurysms requiring operative repair. In that
group, 77% of aortic aneurysms were degenerative, and
23% had other causes including Marfan and Cogan’s syn-
dromes and Takayasu’s arteritis. Forty-six percent of the
young patients had aneurysms proximal to the infrarenal
aorta, significantly more than the 18% found in a group of
randomly selected older control patients (P < .01). The
young and control patients had comparable rates of dia-
betes mellitus, hypertension, and cardiac disease at the
time of operation. Similar to the results of the present
study, Muluk and colleagues20 found that 46% of the
young patients and 6.7% of the control patients had symp-
toms at the time of operation (P < .001). Although the
authors suggested that the survival rate of the young
patients was similar to that of the control group, follow-
up was available for less than two thirds of patients, and
life-table methods were not used as a means of estimating
survival.20
Aortoiliac occlusive disease in the young has been
more extensively described.9,10 Mingoli et al10 examined
the clinical course of 68 patients younger than 45 years
with atherosclerotic aortoiliac occlusive disease requiring
revascularization. Compared with a randomly selected con-
trol group of older patients undergoing aortoiliac recon-
struction, the young patients had a higher prevalence of
tobacco abuse, hypertension, and dyslipidemia and similar
Fig 1. Product-limit estimates of time to death for young
patients (n = 19) and control patients (n = 57) after AAA repair.
The survival rate is not different between the two groups.
Fig 2. Product-limit estimates of time to death after AAA repair
for young patients (n = 19) and the entire cohort of patients older
than 50 years during the study period (n = 1101). The survival
rate is not different between the two groups.
rates of diabetes mellitus, cerebrovascular disease, and car-
diac disease. With life-table methods, similar survival rates
in both the young and older control groups were demon-
strated (68% survival at 5 years for both groups).10 By
using life-table analysis, Harris et al9 also reported no dif-
ference between the survival rates of young and randomly
selected older control patients after aortoiliac reconstruc-
tion (5-year survival, 82% vs 84%; P = not significant).
A number of reports describe cerebrovascular disease
in young patients.11,12,21 Valentine et al11 compared 42
patients younger than 50 years with 110 older control
subjects undergoing carotid endarterectomy for athero-
sclerotic cerebrovascular disease. Stroke as an indication
for operation was significantly more common in the young
patients (48% vs 11%; P < .001). Although ipsilateral
carotid artery restenosis was more frequent in the young
patients (24% vs 3%; P < .001), a trend toward a more
favorable survival rate in the young group compared with
the older group (83% vs 67%; P = .06) was demonstrated
by means of life-table analysis.11 Martin et al12 compared
26 patients younger than 50 years with 30 randomly
selected older control patients who underwent carotid
endarterectomy. Symptoms were more frequent in young
patients than in older patients (92% vs 57%; P = .003);
however, no significant differences were noted between
the young and control groups for restenosis (27% vs 14%;
P = .22) or 5-year survival rate (93% vs 81%; P = .38).12
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Young patients with cerebrovascular disease had a high
prevalence of tobacco abuse, hypertension, diabetes melli-
tus, cardiac disease,11,12,21 and dyslipidemia.12,21
The findings of this study are also similar to earlier
reports describing young patients with atherosclerotic
infrainguinal disease.9,13-15 Valentine et al14 demonstrated
high rates of cardiac and cerebrovascular disease in
patients younger than 50 years with symptomatic lower-
extremity atherosclerosis. Young patients also had high
rates of associated atherosclerotic risk factors, including
hypertension, dyslipidemia, and tobacco use,14 findings
that were confirmed by Levy and colleagues.15 Harris et
al,9 using life-table methods, showed that young patients
had survival rates similar to those of randomly selected
older patients after intervention for infrainguinal athero-
sclerosis. Cardiovascular disease was the predominant
cause of long-term mortality in young patients with symp-
tomatic lower-extremity atherosclerosis.13,14
This study has several limitations. Because of its retro-
spective design, the findings were made on the basis of the
selected data available in the medical records. Despite this,
analysis of survival and cause of death was probably not
adversely affected, because these data were confirmed by
means of the NDI search. In addition, advances in patient
treatment during the study period may have affected the
identification of prevalent cardiovascular diseases and fol-
low-up results. The methods and application of elective
Table IV. Summary of the postoperative course for young and control patients
Young patients Control patients P value
ICU length of stay (d) .99
Mean ± SD 6.1 ± 7.4 6.1 ± 8.5
Median 3 3
Hospital length of stay (d) .40
Mean ± SD 15.0 ± 12.5 12.7 ± 9.9
Median 10 9
Perioperative morbidity
Major complication* 4 (21%) 5 (9%) .22
Moderate complication* 3 (20%) 10 (19%) 1.0
Mild complication* 0 3 (7%) 1.0
*Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg
1997;26:517-38.
ICU, Intensive care unit.
Table V. Summary of follow-up deaths after repair of abdominal aortic aneurysm (perioperative deaths excluded)
Young patients (n = 16) Control patients (n = 52) Entire AAA cohort (n = 1046)
Coronary artery disease 1 (6%) 3 (6%) 168 (16%)
Cerebrovascular disease 1 (6%) 1 (2%) 19 (2%)
Renal failure 1 (6%) 2 (4%) 9 (1%)
Aortic/peripheral atherosclerosis* 1 (6%) 5 (10%) 44 (4%)
Cancer 0 ( 4 (8%) 47 (4%)
Other† 1 (6%) 7 (13%) 107 (10%)
*Aortic/peripheral atherosclerosis included complications of aortic graft infection, mesenteric ischemia, thoracic aortic aneurysm repair, lower-extremity
revascularization, or gangrene.
†Other causes of death included trauma, infection, cirrhosis, complications of chronic lung disease, and gastrointestinal bleeding.
AAA, Abdominal aortic aneurysm.
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cardiac risk assessments changed during the study period,
whereas patients undergoing emergency AAA repair
(more than half of the young patients) had no preopera-
tive assessment. Although these factors may have affected
the estimated prevalence of cardiac disease in both the
young and control groups, we attempted to account for
these differences with time by using a case-control study
design that matched patients by year of operation. Finally,
because of the limited number of young patients with
AAA, the study may have lacked sufficient power to iden-
tify markers of follow-up death. Conversely, the clinical
markers used as a means of assigning the presence or
absence of cardiovascular disease may not have accurately
identified the patients at risk for death during follow-up.
CONCLUSION
AAAs in young patients are rare. After aneurysm
repair, young patients had similar rates of perioperative
morbidity and mortality and follow-up death when com-
pared with control patients. Cardiovascular disease (inclu-
ding non-cardiac vascular disease) was the predominant
cause of death after AAA repair in the young patients.
Compared with an age of more than 50 years at the time
of AAA repair, young age alone was not associated with
increased survival after elimination of aneurysm risk.
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